ROBAXIN

This brand name is authorized in United States. It is also authorized in Canada, Japan, Spain, UK.

Active ingredients

The drug ROBAXIN contains one active pharmaceutical ingredient (API):

1
UNII 125OD7737X - METHOCARBAMOL
 

Methocarbamol is a centrally acting muscle relaxant. Its muscle relaxing action is the result of the inhibition of polysynaptic reflexes in the spinal marrow and subcortical centres.

 
Read more about Methocarbamol

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 ROBAXIN Solution for injection MPI, US: SPL/Old FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
M03BA03 Methocarbamol M Musculo-skeletal system → M03 Muscle relaxants → M03B Muscle relaxants, centrally acting agents → M03BA Carbamic acid esters
Discover more medicines within M03BA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
CA Health Products and Food Branch 01930990, 01932187
ES Centro de información online de medicamentos de la AEMPS 32899
GB Medicines & Healthcare Products Regulatory Agency 25954, 381664
JP 医薬品医療機器総合機構 1225003D1031
US FDA, National Drug Code 0641-6103, 0641-6217, 52244-449, 80425-0020, 80425-0021

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.